Search bioRxiv⌕ Search

Biology subjects

Islam, S. R.

Publications and source records attributed to Islam, S. R..

2 recordsLinked to original sources

Defects in lamin A-Prohibitin crosstalk leads to ROS elevation and OxPhos imbalance in laminocardiomyopathy

Lamins are critical for maintaining nuclear homeostasis, chromosome positioning, and cellular mechanotransduction, which involves the transfer of mechanical signals from the cellular microenvironment to the nucleus. Recent studies have also highlighted the involvement of lamin A in mitochondrial homeostasis and the regulation of reactive oxygen species production. Missense mutations in lamin A are linked to a spectrum of diseases known as laminopathies, which include conditions such as dilated cardiomyopathy (DCM), muscular dystrophy, and progeria. One such mutation, K97E, is associated with DCM, causing severe cardiac complications that can lead to myocardial infarction in extreme cases. Our study reveals a detailed pathogenic cascade in K97E-transfected cells involving disrupted interaction with Prohibitin-2, a key mitochondrial protein. Mitochondria exhibit increased fission, reduced fusion, and fragmentation, due to OPA1 downregulation and DRP1 recruitment driven by actin cytoskeletal remodelling. Impaired Rho-ERK- FAK signalling reduces F-actin assembly, elevating G-actin, which further promotes mitochondrial fission. This feedback loop leads to mitochondrial depolarisation, ATP deficiency, and global metabolic catastrophe, in particular cholesterol metabolism, accompanied by elevated ROS. In cardiomyocytes, such dysfunction may underlie contractile deficits and arrhythmias. Our findings establish PHB2 as a critical node linking nuclear integrity, cytoskeletal architecture, and mitochondrial homeostasis, offering new insights into DCM pathogenesis and therapeutic targets. Our findings elucidate the pivotal role of lamin A in cellular energetics and mechanotransduction, offering novel insights into DCM pathophysiology, which in turn opens avenues for developing targeted therapeutic strategies. TeaserLamin A K97E mutation alters cellular metabolome through disturbed mitochondrial and actin homeostasis in a feedback loop with PHB2 at its hub and causes gross pathogenesis of DCM. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=120 SRC="FIGDIR/small/665267v1_ufig1.gif" ALT="Figure 1"> View larger version (50K): org.highwire.dtl.DTLVardef@176d89aorg.highwire.dtl.DTLVardef@1868703org.highwire.dtl.DTLVardef@109dff8org.highwire.dtl.DTLVardef@14f469a_HPS_FORMAT_FIGEXP M_FIG O_FLOATNOFigure 5C_FLOATNO Gross mitochondrial defects arising from PHB2 and actin perturbations leading to severe metabolic and bioenergetic effects during K97E mutation of lamin A C_FIG

cell biology↗

Identification of glucose-independent metabolic pathways associated with anti-proliferative effect of metformin, their coordinate derangement with cMyc downregulation and reversibility in liver cancer cells.

Several studies indicated anti-cancer effects of metformin in liver cancer. This was attributed to the activation of LKB-AMPK axis, which is associated with anti-hyperglycaemic effect and cytotoxicity. However, despite lack of evidence on cytotoxic effect of physiological metformin concentrations and ability of cancer cells to survive under glucose-deprivation, no study has examined the glucose-independent effect of non-cytotoxic metformin or metabolic reprogramming associated with it. In addition, no study has ever been conducted on reversibility of anti-cancer effects of metformin. Here, the dose-dependent effects of metformin on HepG2 cells were examined in presence and absence of glucose. The longitudinal evolution of metabolome was analyzed along with gene and protein expression as well as their correlations with and reversibility of cellular phenotype and metabolic signatures. Metformin concentrations up to 2.5mM were found to be non-cytotoxic but anti-proliferative irrespective of presence of glucose. Apart from mitochondrial impairment, derangement of fatty acid desaturation, one-carbon, glutathione and polyamine metabolism were associated with non-cytotoxic metformin treatment irrespective of glucose supplementation. Depletion of pantothenic acid, downregulation of essential amino acid uptake, metabolism and purine salvage were identified as novel glucose-independent effects of metformin. These were significantly correlated with cMyc expression and reduction in proliferation. Rescue experiments established reversibility upon metformin withdrawal and tight association between proliferation, metabotype and cMyc expression. Taken together, derangement of novel glucose-independent metabolic pathways and concomitant cMyc downregulation co-ordinately contribute to anti-proliferative effect of metformin even at non-cytotoxic concentrations, which is reversible and may influence its therapeutic utility.

cancer biology↗